Cocrystal Pharma Common Stock (COCP) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.6
-0.53
-0.46
-0.39

Details

Expected EPS
-0.57
Actual EPS
-0.49
Surprise EPS
0.08
Surprise Percent
+14.04%

Description

Cocrystal Pharma Common Stock (COCP) has reported earnings of -0.49 per share for Q4 2024.

0 Comments

Share your thoughts